RAGE regulation and signaling in inflammation and beyond

Journal of Leukocyte Biology

Volumn 94, Issue 1, 2013, Pages 55-68

  Kierdorf, Katrin ^a   Fritz, Günter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

HMGB1; MAPK; NF B; S100

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR INHIBITOR; ANTIINFLAMMATORY AGENT; HIGH MOBILITY GROUP B1 PROTEIN; MONOCLONAL ANTIBODY; NOOTROPIC AGENT; PROTEIN S100B; RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; TTP 448; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; BLOOD VESSEL INJURY; CELL MATURATION; CELL TYPE; DENDRITIC CELL; ENDOTHELIUM; ENDOTHELIUM CELL; GRANULOCYTE; HUMAN; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LIGAND BINDING; MACROPHAGE; MICROGLIA; MOLECULAR MODEL; MONOCYTE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

HMGB1; MAPK; NF-ΚB; S100;

ANIMALS; HUMANS; INFLAMMATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84879593735     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1012519     Document Type: Review

References (176)

1. Akirav, E. M., Preston-Hurlburt, P., Garyu, J., Henegariu, O., Clynes, R., Schmidt, A. M., Herold, K. C. (2012) RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS One 7, e34698.
2. Chen, Y., Akirav, E. M., Chen, W., Henegariu, O., Moser, B., Desai, D., Shen, J. M., Webster, J. C., Andrews, R. C., Mjalli, A. M., Rothlein, R., Schmidt, A. M., Clynes, R., Herold, K. C. (2008) RAGE ligation affects T cell activation and controls T cell differentiation. J. Immunol. 181, 4272-4278.
3. Tian, J., Avalos, A. M., Mao, S. Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., Hua, J., An, L. L., Audoly, L., La Rosa, G., Bierhaus, A., Naworth, P., Marshak-Rothstein, A., Crow, M. K., Fitzgerald, K. A., Latz, E., Kiener, P. A., Coyle, A. J. (2007) Tolllike receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496.
4. Moser, B., Desai, D. D., Downie, M. P., Chen, Y., Yan, S. F., Herold, K., Schmidt, A. M., Clynes, R. (2007) Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J. Immunol. 179, 8051-8058.
5. Dumitriu, I. E., Bianchi, M. E., Bacci, M., Manfredi, A. A., Rovere-Querini, P. (2007) The secretion of HMGB1 is required for the migration of maturing dendritic cells. J. Leukoc. Biol. 81, 84-91.
6. Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., Rovere-Querini, P. (2005) Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174, 7506-7515.
7. Manfredi, A. A., Capobianco, A., Esposito, A., De Cobelli, F., Canu, T., Monno, A., Raucci, A., Sanvito, F., Doglioni, C., Nawroth, P. P., Bierhaus, A., Bianchi, M. E., Rovere-Querini, P., Del Maschio, A. (2008) Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J. Immunol. 180, 2270-2275.
8. Yan, S. F., Yan, S. D., Ramasamy, R., Schmidt, A. M. (2009) Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann. Med. 41, 408-422.
9. Bierhaus, A., Stern, D. M., Nawroth, P. P. (2006) RAGE in inflammation: a new therapeutic target? Curr. Opin. Investig. Drugs 7, 985-991.
10. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004.
11. Fritz, G. (2011) RAGE: a single receptor fits multiple ligands. Trends Biochem. Sci. 36, 625-632.
12. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., Clauss, M. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997.
13. Fu, M. X., Wells-Knecht, K. J., Blackledge, J. A., Lyons, T. J., Thorpe, S. R., Baynes, J. W. (1994) Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43, 676-683.
14. Leclerc, E., Fritz, G., Vetter, S. W., Heizmann, C. W. (2009) Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 1793, 993-1007.
15. Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901.
16. Park, H., Boyington, J. C. (2010) The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J. Biol. Chem. 285, 40762-40770.
17. Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., Okamoto, H., Shimura, S., Karasawa, T., Yonekura, H., Yamamoto, H. (2011) Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J. Immunol. 186, 3248-3257.
18. Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., Nawroth, P. P. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198, 1507-1515.
19. Ma, W., Rai, V., Hudson, B. I., Song, F., Schmidt, A. M., Barile, G. R. (2012) RAGE binds C1q and enhances C1q-mediated phagocytosis. Cell. Immunol. 274, 72-82.
20. Rai, V., Toure, F., Chitayat, S., Pei, R., Song, F., Li, Q., Zhang, J., Rosario, R., Ramasamy, R., Chazin, W.J., Schmidt, A. M. (2012) Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. J. Exp. Med. 209, 2339-2350.
21. Haupt, C., Bereza, M., Kumar, S. T., Kieninger, B., Morgado, I., Hortschansky, P., Fritz, G., Rocken, C., Horn, U., Fandrich, M. (2011) Pattern recognition with a fibril-specific antibody fragment reveals the surface variability of natural amyloid fibrils. J. Mol. Biol. 408, 529-540.
22. Du Yan, S., Zhu, H., Fu, J., Yan, S. F., Roher, A., Tourtellotte, W. W., Rajavashisth, T., Chen, X., Godman, G. C., Stern, D., Schmidt, A. M. (1997) Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 5296-5301.
23. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., Schmidt, A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
24. Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., Zlokovic, B. V. (1998) Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734-743.
25. Borsi, V., Cerofolini, L., Fragai, M., Luchinat, C. (2012) NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment. J Biomol. NMR 54, 285-290.
26. Rai, V., Maldonado, A. Y., Burz, D. S., Reverdatto, S., Yan, S. F., Schmidt, A. M., Shekhtman, A. (2012) Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J. Biol. Chem. 287, 5133-5144.
27. (2011) The PyMOL Molecular Graphics System, Schrödinger, LLC. Schrödinger, New York, NY, USA.
28. Huttunen, H. J., Fages, C., Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924.
29. Koch, M., Chitayat, S., Dattilo, B. M., Schiefner, A., Diez, J., Chazin, W. J., Fritz, G. (2010) Structural basis for ligand recognition and activation of RAGE. Structure 18, 1342-1352.
30. Dattilo, B. M., Fritz, G., Leclerc, E., Kooi, C. W., Heizmann, C. W., Chazin, W. J. (2007) The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46, 6957-6970.
31. Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., Galichet, A. (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 282, 31317-31331.
32. Nawroth, P., Bierhaus, A., Marrero, M., Yamamoto, H., Stern, D. M. (2005) Atherosclerosis and restenosis: is there a role for RAGE? Curr. Diab. Rep. 5, 11-16.
33. Bierhaus, A., Nawroth, P. P. (2009) Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52, 2251-2263.
34. Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Kloting, I., Morcos, M., Hofmann, M., Tritschler, H., Weigle, B., Kasper, M., Smith, M., Perry, G., Schmidt, A. M., Stern, D. M., Haring, H. U., Schleicher, E., Nawroth, P. P. (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-κB. Diabetes 50, 2792-2808.
35. Sunahori, K., Yamamura, M., Yamana, J., Takasugi, K., Kawashima, M., Makino, H. (2006) Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 54, 97-104.
36. Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., De Caterina, R. (2002) Advanced glycation end products activate endothelium through signaltransduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105, 816-822.
37. Greten, J., Kreis, I., Wiesel, K., Stier, E., Schmidt, A. M., Stern, D. M., Ritz, E., Waldherr, R., Nawroth, P. P. (1996) Receptors for advance glycation end-products (AGE)-expression by endothelial cells in non-diabetic uraemic patients. Nephrol. Dial. Transplant. 11, 786-790.
38. Bierhaus, A., Ritz, E., Nawroth, P. P. (1996) Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease. Nephrol. Dial. Transplant. 11(Suppl. 5), 87-90.
39. Tanji, N., Markowitz, G.S., Fu, C., Kislinger, T., Taguchi, A., Pischetsrieder, M., Stern, D., Schmidt, A.M., D'Agati, V.D. (2000) Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J. Am. Soc. Nephrol. 11, 1656-1666.
40. Kislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran L. J., Jr., Taguchi, A., Olson, K., Bucciarelli, L., Goova, M., Hofmann, M. A., Cataldegirmen, G., D'Agati, V., Pischetsrieder, M., Stern, D. M., Schmidt, A. M. (2001) Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 21, 905-910.
41. Wendt, T., Harja, E., Bucciarelli, L., Qu, W., Lu, Y., Rong, L. L., Jenkins, D. G., Stein, G., Schmidt, A. M., Yan, S. F. (2006) RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185, 70-77.
42. Harja, E., Bu, D. X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., Kalea, A. Z., Lu, Y., Rosario, R. H., Oruganti, S., Nikolla, Z., Belov, D., Lalla, E., Ramasamy, R., Yan, S. F., Schmidt, A. M. (2008) Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/-mice. J. Clin. Invest. 118, 183-194.
43. Fang, F., Lue, L. F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Schmidt, A. M., Chen, J. X., Yan, S. S. (2010) RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J. 24, 1043-1055.
44. Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., Domenici, L. (2008) Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-β-mediated cortical synaptic dysfunction. J. Neurosci. 28, 3521-3530.
45. Arancio, O., Zhang, H. P., Chen, X., Lin, C., Trinchese, F., Puzzo, D., Liu, S., Hegde, A., Yan, S. F., Stern, A., Luddy, J. S., Lue, L. F., Walker, D. G., Roher, A., Buttini, M., Mucke, L., Li, W., Schmidt, A. M., Kindy, M., Hyslop, P. A., Stern, D. M., Du Yan, S. S. (2004) RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice. EMBO J. 23, 4096-4105.
46. D'Agati, V., Schmidt, A. M. (2010) RAGE and the pathogenesis of chronic kidney disease. Nat. Rev. Nephrol. 6, 352-360.
47. Yan, S. F., Ramasamy, R., Schmidt, A. M. (2010) The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ. Res. 106, 842-853.
48. Rojas, A., Figueroa, H., Morales, E. (2010) Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis 31, 334-341.
49. Buckley, S. T., Ehrhardt, C. (2010) The receptor for advanced glycation end products (RAGE) and the lung. J. Biomed. Biotechnol. 2010, 917108.
50. Ramasamy, R., Yan, S. F., Schmidt, A. M. (2012) The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul. Pharmacol. 57, 160-167.
51. Sorci, G., Riuzzi, F., Giambanco, I., Donato, R. (2013) RAGE in tissue homeostasis, repair and regeneration. Biochim. Biophys. Acta 1833, 101-109.
52. Bierhaus, A., Illmer, T., Kasper, M., Luther, T., Quehenberger, P., Tritschler, H., Wahl, P., Ziegler, R., Muller, M., Nawroth, P. P. (1997) Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96, 2262-2271.
53. Boelke, E., Storck, M., Buttenschoen, K., Berger, D., Hannekum, A. (2000) Endotoxemia and mediator release during cardiac surgery. Angiology 51, 743-749.
54. Mazzini, G. S., Schaf, D. V., Oliveira, A. R., Goncalves, C. A., Bello-Klein, A., Bordignon, S., Bruch, R. S., Campos, G. F., Vassallo, D. V., Souza, D. O., Portela, L. V. (2005) The ischemic rat heart releases S100B. Life Sci. 77, 882-889.
55. Ehlermann, P., Eggers, K., Bierhaus, A., Most, P., Weichenhan, D., Greten, J., Nawroth, P. P., Katus, H. A., Remppis, A. (2006) Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc. Diabetol. 5, 6.
56. Luan, Z. G., Zhang, H., Yang, P. T., Ma, X. C., Zhang, C., Guo, R. X. (2010) HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells. Immunobiology 215, 956-962.
57. Tanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y., Yamamoto, H. (2000) The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275, 25781-25790.
58. Goldin, A., Beckman, J. A., Schmidt, A. M., Creager, M. A. (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114, 597-605.
59. Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., Stern, D. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96, 1395-1403.
60. Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., Suffredini, A. F. (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101, 2652-2660.
61. Huang, W., Liu, Y., Li, L., Zhang, R., Liu, W., Wu, J., Mao, E., Tang, Y. (2012) HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways. Inflammation 35, 350-362.
62. Hirose, A., Tanikawa, T., Mori, H., Okada, Y., Tanaka, Y. (2010) Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett. 584, 61-66.
63. Frommhold, D., Kamphues, A., Hepper, I., Pruenster, M., Lukic, I. K., Socher, I., Zablotskaya, V., Buschmann, K., Lange-Sperandio, B., Schymeinsky, J., Ryschich, E., Poeschl, J., Kupatt, C., Nawroth, P. P., Moser, M., Walzog, B., Bierhaus, A., Sperandio, M. (2010) RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 116, 841-849.
64. Frommhold, D., Kamphues, A., Dannenberg, S., Buschmann, K., Zablotskaya, V., Tschada, R., Lange-Sperandio, B., Nawroth, P. P., Poeschl, J., Bierhaus, A., Sperandio, M. (2011) RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner. BMC Immunol. 12, 56.
65. Li, M., Shang, D. S., Zhao, W. D., Tian, L., Li, B., Fang, W. G., Zhu, L., Man, S. M., Chen, Y. H. (2009) Amyloid β interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J. Immunol. 182, 5778-5788.
66. Zhou, Z., Wang, K., Penn, M. S., Marso, S. P., Lauer, M. A., Forudi, F., Zhou, X., Qu, W., Lu, Y., Stern, D. M., Schmidt, A. M., Lincoff, A. M., Topol, E. J. (2003) Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 107, 2238-2243.
67. Touré, F., Fritz, G., Li, Q., Rai, V., Daffu, G., Zou, Y. S., Rosario, R., Ramasamy, R., Alberts, A. S., Yan, S. F., Schmidt, A. M. (2012) Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways. Circ. Res. 110, 1279-1293.
68. Wang, K., Zhou, Z., Zhang, M., Fan, L., Forudi, F., Zhou, X., Qu, W., Lincoff, A. M., Schmidt, A. M., Topol, E. J., Penn, M. S. (2006) Peroxisome proliferator-activated receptor α down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J. Pharmacol. Exp. Ther. 317, 37-43.
69. Yu, W., Liu-Bryan, R., Stevens, S., Damanahalli, J. K., Terkeltaub, R. (2012) RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity. Atherosclerosis 222, 417-425.
70. Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., Schmidt, A. M. (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272, 17810-17814.
71. Li, J. H., Wang, W., Huang, X. R., Oldfield, M., Schmidt, A. M., Cooper, M. E., Lan, H. Y. (2004) Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am. J. Pathol. 164, 1389-1397.
72. Spiekerkoetter, E., Guignabert, C., de Jesus Perez, V., Alastalo, T. P., Powers, J. M., Wang, L., Lawrie, A., Ambartsumian, N., Schmidt, A. M., Berryman, M., Ashley, R. H., Rabinovitch, M. (2009) S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ. Res. 105, 639-647.
73. Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., Liliensiek, B., Nawroth, P. P., Stern, D. M., Schmidt, A. M., Naka, Y. (2003) Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Invest. 111, 959-972.
74. Gawdzik, J., Mathew, L., Kim, G., Puri, T. S., Hofmann Bowman, M. A. (2011) Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease. Am. J. Nephrol. 33, 250-259.
75. Reddy, M. A., Li, S. L., Sahar, S., Kim, Y. S., Xu, Z. G., Lanting, L., Natarajan, R. (2006) Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 281, 13685-13693.
76. 3integrin engagement. Biochem. Biophys. Res. Commun. 297, 261-266.
77. Tanikawa, T., Okada, Y., Tanikawa, R., Tanaka, Y. (2009) Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J. Vasc. Res. 46, 572-580.
78. Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C., De Cesare, D., De Blasis, G., Muraro, R., Bei, R., Chiarelli, F., Schmidt, A. M., Cuccurullo, F., Mezzetti, A. (2003) The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108, 1070-1077.
79. Park, I. H., Yeon, S. I., Youn, J. H., Choi, J. E., Sasaki, N., Choi, I. H., Shin, J. S. (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol. Immunol. 40, 1203-1211.
80. Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donato, R., Rauvala, H. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105.
81. Adami, C., Sorci, G., Blasi, E., Agneletti, A. L., Bistoni, F., Donato, R. (2001) S100B expression in and effects on microglia. Glia 33, 131-142.
82. Schmidt, A. M., Yan, S. D., Yan, S. F., Stern, D. M. (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108, 949-955.
83. Ostendorp, T., Leclerc, E., Galichet, A., Koch, M., Demling, N., Weigle, B., Heizmann, C. W., Kroneck, P. M., Fritz, G. (2007) Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26, 3868-3878.
84. Kligman, D., Marshak, D. R. (1985) Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA 82, 7136-7139.
85. Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., Makita, Z. (2001) Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 888, 256-262.
86. Miller, M. C., Tavares, R., Johanson, C. E., Hovanesian, V., Donahue, J. E., Gonzalez, L., Silverberg, G. D., Stopa, E. G. (2008) Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 1230, 273-280.
87. Yan, S. D., Bierhaus, A., Nawroth, P. P., Stern, D. M. (2009) RAGE and Alzheimer's disease: a progression factor for amyloid-β-induced cellular perturbation? J. Alzheimers Dis. 16, 833-843.
88. Deane, R., Du Yan, S., Submamaryan, R.K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., Zhu, H., Ghiso, J., Frangione, B., Stern, A., Schmidt, A.M., Armstrong, D.L., Arnold, B., Liliensiek, B., Nawroth, P., Hofman, F., Kindy, M., Stern, D., Zlokovic, B. (2003) RAGE mediates amyloid-β peptide transport across the bloodbrain barrier and accumulation in brain. Nat. Med. 9, 907-913.
89. Liu, R., Wu, C. X., Zhou, D., Yang, F., Tian, S., Zhang, L., Zhang, T. T., Du, G. H. (2012) Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis. BMC Med. 10, 105.
90. Kögel, D., Peters, M., Konig, H. G., Hashemi, S. M., Bui, N. T., Arolt, V., Rothermundt, M., Prehn, J. H. (2004) S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience 127, 913-920.
91. Villarreal, A., Aviles Reyes, R. X., Angelo, M. F., Reines, A. G., Ramos, A. J. (2011) S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. J. Neurochem. 117, 321-332.
92. Dukic-Stefanovic, S., Gasic-Milenkovic, J., Deuther-Conrad, W., Munch, G. (2003) Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J. Neurochem. 87, 44-55.
93. Bianchi, R., Adami, C., Giambanco, I., Donato, R. (2007) S100B binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 81, 108-118.
94. Bianchi, R., Giambanco, I., Donato, R. (2010) S100B/RAGE-dependent activation of microglia via NF-κB and AP-1 co-regulation of COX-2 expression by S100B, IL-1β and TNF-α. Neurobiol. Aging 31, 665-677.
95. Bianchi, R., Kastrisianaki, E., Giambanco, I., Donato, R. (2011) S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J. Biol. Chem. 286, 7214-7226.
96. Zhang, L., Liu, W., Alizadeh, D., Zhao, D., Farrukh, O., Lin, J., Badie, S. A., Badie, B. (2011) S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway. Glia 59, 486-498.
97. Yeh, C. H., Sturgis, L., Haidacher, J., Zhang, X. N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., Denner, L. (2001) Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes 50, 1495-1504.
98. Shanmugam, N., Kim, Y. S., Lanting, L., Natarajan, R. (2003) Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J. Biol. Chem. 278, 34834-34844.
99. Rouhiainen, A., Kuja-Panula, J., Wilkman, E., Pakkanen, J., Stenfors, J., Tuominen, R. K., Lepantalo, M., Carpen, O., Parkkinen, J., Rauvala, H. (2004) Regulation of monocyte migration by amphoterin (HMGB1). Blood 104, 1174-1182.
100. Martinez, F. O., Sica, A., Mantovani, A., Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461.
101. Sica, A., Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795.
102. Lawrence, T., Natoli, G. (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761.
103. Webster, L., Abordo, E. A., Thornalley, P. J., Limb, G. A. (1997) Induction of TNF α and IL-1 β mRNA in monocytes by methylglyoxal-and advanced glycated endproduct-modified human serum albumin. Biochem. Soc. Trans. 25, 250S.
104. Kokkola, R., Andersson, A., Mullins, G., Ostberg, T., Treutiger, C. J., Arnold, B., Nawroth, P., Andersson, U., Harris, R. A., Harris, H. E. (2005) RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1-9.
105. Juranek, J.K., Geddis, M.S., Song, F., Zhang, J., Garcia, J., Rosario, R., Yan, S. F., Brannagan, T. H., Schmidt, A. M. (2013) RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 62, 931-943.
106. Chang, J. S., Wendt, T., Qu, W., Kong, L., Zou, Y. S., Schmidt, A. M., Yan, S. F. (2008) Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ. Res. 102, 905-913.
107. Xu, Y., Toure, F., Qu, W., Lin, L., Song, F., Shen, X., Rosario, R., Garcia, J., Schmidt, A. M., Yan, S. F. (2010) Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages. J. Biol. Chem. 285, 23233-23240.
108. Nakajima, T., Iikura, M., Okayama, Y., Matsumoto, K., Uchiyama, C., Shirakawa, T., Yang, X., Adra, C. N., Hirai, K., Saito, H. (2004) Identification of granulocyte subtype-selective receptors and ion channels by using a high-density oligonucleotide probe array. J. Allergy Clin. Immunol. 113, 528-535.
109. Appelberg, R. (2007) Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol. 15, 87-92.
110. Collison, K. S., Parhar, R. S., Saleh, S. S., Meyer, B. F., Kwaasi, A. A., Hammami, M. M., Schmidt, A. M., Stern, D. M., Al-Mohanna, F. A. (2002) RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J. Leukoc. Biol. 71, 433-444.
111. Zen, K., Chen, C. X., Chen, Y. T., Wilton, R., Liu, Y. (2007) Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J. Immunol. 178, 2483-2490.
112. Berthelot, F., Fattoum, L., Casulli, S., Gozlan, J., Marechal, V., Elbim, C. (2012) The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration. J. Innate Immun. 4, 41-58.
113. Orlova, V. V., Choi, E. Y., Xie, C., Chavakis, E., Bierhaus, A., Ihanus, E., Ballantyne, C. M., Gahmberg, C. G., Bianchi, M. E., Nawroth, P. P., Chavakis, T. (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26, 1129-1139.
114. Wittkowski, H., Sturrock, A., van Zoelen, M. A., Viemann, D., van der Poll, T., Hoidal, J. R., Roth, J., Foell, D. (2007) Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit. Care Med. 35, 1369-1375.
115. Ye, F., Foell, D., Hirono, K. I., Vogl, T., Rui, C., Yu, X., Watanabe, S., Watanabe, K., Uese, K., Hashimoto, I., Roth, J., Ichida, F., Miyawaki, T. (2004) Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am. J. Cardiol. 94, 840-844.
116. Foell, D., Ichida, F., Vogl, T., Yu, X., Chen, R., Miyawaki, T., Sorg, C., Roth, J. (2003) S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 361, 1270-1272.
117. Foell, D., Kane, D., Bresnihan, B., Vogl, T., Nacken, W., Sorg, C., Fitzgerald, O., Roth, J. (2003) Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 42, 1383-1389.
118. Toure, F., Zahm, J. M., Garnotel, R., Lambert, E., Bonnet, N., Schmidt, A. M., Vitry, F., Chanard, J., Gillery, P., Rieu, P. (2008) Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem. J. 416, 255-261.
119. Omori, K., Ohira, T., Uchida, Y., Ayilavarapu, S., Batista E. L., Jr., Yagi, M., Iwata, T., Liu, H., Hasturk, H., Kantarci, A., Van Dyke, T. E. (2008) Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J. Leukoc. Biol. 84, 292-301.
120. Trivedi, S. G., Lloyd, C. M. (2007) Eosinophils in the pathogenesis of allergic airways disease. Cell. Mol. Life Sci. 64, 1269-1289.
121. Curran, C. S., Bertics, P. J. (2011) Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-δ phosphorylation and enhanced viability in response to the RAGE ligand, S100B. Int. Immunol. 23, 713-728.
122. Messmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K. J., Chiorazzi, N. (2004) High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173, 307-313.
123. Rovere-Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Muller, S., Iannacone, M., Traversari, C., Bianchi, M. E., Manfredi, A. A. (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825-830.
124. Dumitriu, I. E., Baruah, P., Bianchi, M. E., Manfredi, A. A., Rovere-Querini, P. (2005) Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35, 2184-2190.
125. Yang, D., Chen, Q., Yang, H., Tracey, K. J., Bustin, M., Oppenheim, J. J. (2007) High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81, 59-66.
126. Chen, Y., Yan, S. S., Colgan, J., Zhang, H. P., Luban, J., Schmidt, A. M., Stern, D., Herold, K. C. (2004) Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J. Immunol. 173, 1399-1405.
127. Moser, B., Szabolcs, M. J., Ankersmit, H. J., Lu, Y., Qu, W., Weinberg, A., Herold, K. C., Schmidt, A. M. (2007) Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am. J. Transplant. 7, 293-302.
128. Mu, L., Zhang, Y., Sun, B., Wang, J., Xie, X., Li, N., Zhang, J., Kong, Q., Liu, Y., Han, Z., Wang, G., Fu, Z., Yu, B., Li, G., Li, H. (2011) Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms. Clin. Immunol. 141, 36-48.
129. Wild, C. A., Bergmann, C., Fritz, G., Schuler, P., Hoffmann, T. K., Lotfi, R., Westendorf, A., Brandau, S., Lang, S. (2012) HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int. Immunol. 24, 485-494.
130. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145.
131. Takeda, K., Akira, S. (2004) Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 34, 73-82.
132. Kawai, T., Akira, S. (2006) Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137.
133. Corbin, B. D., Seeley, E. H., Raab, A., Feldmann, J., Miller, M. R., Torres, V. J., Anderson, K. L., Dattilo, B. M., Dunman, P. M., Gerads, R., Caprioli, R. M., Nacken, W., Chazin, W. J., Skaar, E. P. (2008) Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319, 962-965.
134. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., Zychlinsky, A. (2004) Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535.
135. Yuzawa, S., Opatowsky, Y., Zhang, Z., Mandiyan, V., Lax, I., Schlessinger, J. (2007) Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 130, 323-334.
136. Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., Shekhtman, A. (2008) Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J. Biol. Chem. 283, 27255-27269.
137. Xie, J., Burz, D. S., He, W., Bronstein, I. B., Lednev, I., Shekhtman, A. (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282, 4218-4231.
138. Chan, F. K. (2007) Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 37, 101-107.
139. Kramer, J. M., Yi, L., Shen, F., Maitra, A., Jiao, X., Jin, T., Gaffen, S. L. (2006) Evidence for ligand-independent multimerization of the IL-17 receptor. J. Immunol. 176, 711-715.
140. Yang, J., Reth, M. (2010) Oligomeric organization of the B-cell antigen receptor on resting cells. Nature 467, 465-469.
141. Schraml, P., Bendik, I., Ludwig, C. U. (1997) Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma. Cancer Res. 57, 3669-3671.
142. Bartling, B., Hofmann, H. S., Weigle, B., Silber, R. E., Simm, A. (2005) Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26, 293-301.
143. Gebhardt, C., Riehl, A., Durchdewald, M., Nemeth, J., Furstenberger, G., Muller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P. P., Hess, J., Angel, P. (2008) RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205, 275-285.
144. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., Coyle, A. J. (2010) HMGB1 and RAGE in inflammation and cancer Annu. Rev. Immunol. 28, 367-388.
145. Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., Schmidt, A. M. (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22, 1572-1580.
146. Sterenczak, K. A., Willenbrock, S., Barann, M., Klemke, M., Soller, J. T., Eberle, N., Nolte, I., Bullerdiek, J., Murua Escobar, H. (2009) Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 434, 35-42.
147. Kalea, A. Z., Reiniger, N., Yang, H., Arriero, M., Schmidt, A. M., Hudson, B. I. (2009) Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J. 23, 1766-1774.
148. Kalea, A. Z., Schmidt, A. M., Hudson, B. I. (2011) Alternative splicing of RAGE: roles in biology and disease. Front. Biosci. 17, 2756-2770.
149. Nishizawa, Y., Koyama, H. (2008) Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in endstage renal disease. J. Ren. Nutr. 18, 76-82.
150. Srikrishna, G., Nayak, J., Weigle, B., Temme, A., Foell, D., Hazelwood, L., Olsson, A., Volkmann, N., Hanein, D., Freeze, H. H. (2010) Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J. Cell. Biochem. 110, 645-659.
151. Park, S. J., Kleffmann, T., Hessian, P. A. (2011) The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type RAGE with the G82S polymorphic variant. J. Biol. Chem. 286, 21384-21392.
152. Zhang, L., Bukulin, M., Kojro, E., Roth, A., Metz, V. V., Fahrenholz, F., Nawroth, P. P., Bierhaus, A., Postina, R. (2008) Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J. Biol. Chem. 283, 35507-35516.
153. Raucci, A., Cugusi, S., Antonelli, A., Barabino, S. M., Monti, L., Bierhaus, A., Reiss, K., Saftig, P., Bianchi, M. E. (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22, 3716-3727.
154. Galichet, A., Weibel, M., Heizmann, C. W. (2008) Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochem. Biophys. Res. Commun. 370, 1-5.
155. Metz, V. V., Kojro, E., Rat, D., Postina, R. (2012) Induction of RAGE shedding by activation of G protein-coupled receptors. PLoS One 7, e41823.
156. Hsieh, H. L., Schafer, B. W., Weigle, B., Heizmann, C. W. (2004) S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem. Biophys. Res. Commun. 316, 949-959.
157. Watanabe, T., Keino, H., Sato, Y., Kudo, A., Kawakami, H., Okada, A. A. (2009) High mobility group box protein-1 in experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 50, 2283-2290.
158. Aris, J. P., Elios, M. C., Bimstein, E., Wallet, S. M., Cha, S., Lakshmyya, K. N., Katz, J. (2010) Gingival RAGE expression in calorie-restricted versus ad libitum-fed rats. J. Periodontol. 81, 1481-1487.
159. Campo, I., Morbini, P., Zorzetto, M., Tinelli, C., Brunetta, E., Villa, C., Bombieri, C., Cuccia, M., Agostini, C., Bozzi, V., Facoetti, A., Ferrarotti, I., Mazzola, P., Scabini, R., Semenzato, G., Pignatti, P. F., Pozzi, E., Luisetti, M. (2007) Expression of receptor for advanced glycation end products in sarcoid granulomas. Am. J. Respir. Crit. Care Med. 175, 498-506.
160. Sterenczak, K. A., Kleinschmidt, S., Wefstaedt, P., Eberle, N., Hewicker-Trautwein, M., Bullerdiek, J., Nolte, I., Murua Escobar, H. (2011) Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis). Anticancer Res. 31, 1541-1548.
161. Wei, W., Chen, M., Zhu, Y., Wang, J., Zhu, P., Li, Y., Li, J. (2012) Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts. J. Nutr. Biochem. 23, 1333-1340.
162. Andras, I. E., Eum, S. Y., Huang, W., Zhong, Y., Hennig, B., Toborek, M. (2010) HIV-1-induced amyloid β accumulation in brain endothelial cells is attenuated by simvastatin. Mol. Cell. Neurosci. 43, 232-243.
163. Perrone, L., Peluso, G., Melone, M. A. (2008) RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes. J. Cell. Physiol. 217, 60-71.
164. Sbai, O., Devi, T. S., Melone, M. A., Feron, F., Khrestchatisky, M., Singh, L. P., Perrone, L. (2010) RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J. Cell Sci. 123, 4332-4339.
165. Sevillano, N., Giron, M. D., Salido, M., Vargas, A. M., Vilches, J., Salto, R. (2009) Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses. J. Biochem. 145, 21-30.
166. Platta, H. W., Stenmark, H. (2011) Endocytosis and signaling. Curr. Opin. Cell Biol. 23, 393-403.
167. Parachoniak, C. A., Park, M. (2012) Dynamics of receptor trafficking in tumorigenicity. Trends Cell Biol. 22, 231-240.
168. Haglund, K., Rusten, T. E., Stenmark, H. (2007) Aberrant receptor signaling and trafficking as mechanisms in oncogenesis. Crit. Rev. Oncog. 13, 39-74.
169. Yamagishi, S., Matsui, T. (2010) Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker. Front. Biosci. (Elite Ed.). 2, 1184-1195.
170. Yan, S. F., Ramasamy, R., Schmidt, A. M. (2010) Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem. Pharmacol. 79, 1379-1386.
171. Christaki, E., Opal, S. M., Keith J. C., Jr., Kessimian, N., Palardy, J. E., Parejo, N. A., Tan, X. Y., Piche-Nicholas, N., Tchistiakova, L., Vlasuk, G. P., Shields, K. M., Feldman, J. L., Lavallie, E. R., Arai, M., Mounts, W., Pittman, D. D. (2011) A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock 35, 492-498.
172. Melnikova, I. (2007) Therapies for Alzheimer's disease. Nat. Rev. Drug Discov. 6, 341-342.
173. Creed, M. C., Milgram, N. W. (2010) Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications. Age (Dordr). 32, 365-384.
174. Sabbagh, M. N., Agro, A., Bell, J., Aisen, P. S., Schweizer, E., Galasko, D. (2011) PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease. Alzheimer. Dis. Assoc. Disord. 25, 206-212. 175 Pfizer, Alzheimer's Disease Cooperative Study (2011) A phase 2 study evaluating the efficacy and safety of PF 04494700 in mild to moderate Alzheimer's disease. ClinicalTrials. gov. National Institutes of Health, Washington, DC, USA.
175. Pfizer, Alzheimer's Disease Cooperative Study (2011) A phase 2 study evaluating the efficacy and safety of PF 04494700 in mild to moderate Alzheimer's disease. ClinicalTrials. gov. National Institutes of Health, Washington, DC, USA
176. Deane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., Thiyagarajan, M., Zarcone, T., Fritz, G., Friedman, A. E., Miller, B. L., Zlokovic, B. V. (2012) A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122, 1377-1392.